Loading...

Insulet Corporation

PODDNASDAQ
HealthcareMedical - Devices
$314.46
$-2.21(-0.70%)

Insulet Corporation (PODD) Stock Overview

Explore Insulet Corporation’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
22.07%
22.07%
Profit Growth
$5.72
102.76%
EPS Growth
$5.72
101.69%
Operating Margin
16.26%
40.41%
ROE
40.62%
102.76%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
8
Hold
1
Sell
0
Strong Sell
0

Price Targets

Low$200.00
Average$261.00
High$322.00

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

CEO

Ms. Ashley A. McEvoy

Employees

3,900

Headquarters

100 Nagog Park, Acton, MA

Founded

2007

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.